Casin Real Estate Development Group Co.Ltd(000838) : Announcement on abnormal fluctuations in stock trading

Securities code: Casin Real Estate Development Group Co.Ltd(000838) securities abbreviation: Casin Real Estate Development Group Co.Ltd(000838) Announcement No.: 2022006

Casin Real Estate Development Group Co.Ltd(000838)

Announcement on abnormal fluctuations in stock trading

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.

1、 Abnormal fluctuations in stock trading

Casin Real Estate Development Group Co.Ltd(000838) (hereinafter referred to as "the company" and "the company") (Securities abbreviation: Casin Real Estate Development Group Co.Ltd(000838) ; securities code: Casin Real Estate Development Group Co.Ltd(000838) ) the deviation of the closing price increase of the stock for two consecutive trading days on March 1 and 2, 2022 is more than 20%. According to the relevant provisions of the trading rules of Shenzhen Stock Exchange, it is an abnormal fluctuation of stock trading.

2、 Description of the company's concern and verification

In view of the abnormal fluctuation of stock trading, the company checked relevant matters and inquired in writing with the company's management, controlling shareholders and actual controllers. The relevant information is explained as follows: 1. There is no need to correct or supplement the information disclosed by the company in the early stage;

2. The company has not found any unpublished material information that may or has had a great impact on the stock trading price of the company reported by the public media recently;

3. The company's operating conditions and internal and external operating environment have not changed significantly recently;

4. The company, the controlling shareholder and the actual controller have no major matters that should be disclosed but have not been disclosed or are in the planning stage;

5. During the abnormal fluctuation period of the company's stock trading, the controlling shareholder and actual controller of the company do not buy or sell the company's shares.

3、 Whether there is undisclosed information

The board of directors of the company confirms that the company has no undisclosed matters or planning, negotiation, intention, agreement, etc. related to the matters that should be disclosed in accordance with the relevant provisions of the Listing Rules of Shenzhen Stock Exchange; The board of directors has not been informed that the company has undisclosed information that has a great impact on the trading price of the company's shares and their derivatives that should be disclosed in accordance with the stock listing rules of Shenzhen Stock Exchange and other relevant provisions; There is no need to correct or supplement the information disclosed by the company in the previous period.

4、 Risk tips

1. Through self-examination, the company does not violate the fair disclosure of information.

2. The company disclosed the 2021 annual performance forecast (Announcement No.: 2022004) on January 27, 2022. As of the disclosure date of this announcement, there is no situation that the above performance forecast should be corrected. The specific financial data of the company in 2021 should be subject to the company's 2021 annual report.

3. The company solemnly reminds investors that the designated information disclosure media of the company are China Securities News, securities times, Shanghai Securities News and cninfo( http://www.cn.info.com.cn. ), all information of the company shall be subject to the information published in the above designated media. The company will timely disclose the information in strict accordance with the provisions and requirements of relevant laws and regulations, and invite investors to invest rationally and pay attention to investment risks.

It is hereby announced.

Casin Real Estate Development Group Co.Ltd(000838) board of directors March 3, 2022

- Advertisment -